Obesity News

BOSTON — In this Healio video exclusive, Donna H. Ryan, MD, and Christopher Still, DO, FACP, discuss the optimal treatment strategy for patients who require weight loss beyond diet and lifestyle changes.

DALLAS — Oral semaglutide improves HbA1c and may prevent progression to type 2 diabetes for adults with prediabetes, according to a speaker at ObesityWeek.

DALLAS — New data presented at ObesityWeek demonstrate an encouraging early profile of an investigational dual GLP-1/GIP receptor agonist in healthy adults, according to a speaker at ObesityWeek.

Study data suggest that children and adolescents with a high polygenic risk score for polycystic ovary syndrome tend to have a higher BMI and are more likely to develop obesity.

With its impact on individuals and society, addressing obesity requires a multidisciplinary approach that combines medical expertise, research and public health initiatives.

DALLAS — Initiation and continued use of certain antidepressants may cause more weight gain over 2 years, according to research presented at ObesityWeek.

DALLAS — Older adults who received anti-obesity medications lost a similar amount of weight at 3 to 5 years as younger adults, with no increased side effects, according to research presented at ObesityWeek.

DALLAS — In this Healio video exclusive, Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS, discusses cultural competency with regard to obesity care.

DALLAS — People with rare monogenic forms of obesity may reduce their risk for metabolic syndrome with setmelanotide therapy, according to research presented at ObesityWeek.

DALLAS — Tailoring childhood obesity treatment to patients’ specific needs may promote adherence and improve outcomes, according to research presented at ObesityWeek.